- Home
- ING vs COR Comparison
ING vs COR Comparison
Compare ING & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ING
- COR
- Stock Information
- Founded
- ING 1991
- COR 2001
- Country
- ING Netherlands
- COR United States
- Employees
- ING N/A
- COR N/A
- Industry
- ING Commercial Banks
- COR Other Pharmaceuticals
- Sector
- ING Finance
- COR Health Care
- Exchange
- ING Nasdaq
- COR Nasdaq
- Market Cap
- ING 48.3B
- COR 44.4B
- IPO Year
- ING N/A
- COR N/A
- Fundamental
- Price
- ING $16.29
- COR $242.06
- Analyst Decision
- ING Buy
- COR Buy
- Analyst Count
- ING 1
- COR 11
- Target Price
- ING N/A
- COR $268.09
- AVG Volume (30 Days)
- ING 2.5M
- COR 1.2M
- Earning Date
- ING 02-06-2025
- COR 02-05-2025
- Dividend Yield
- ING 8.37%
- COR 0.91%
- EPS Growth
- ING N/A
- COR N/A
- EPS
- ING 1.23
- COR 7.53
- Revenue
- ING $19,192,505,011.00
- COR $293,958,599,000.00
- Revenue This Year
- ING N/A
- COR $9.98
- Revenue Next Year
- ING N/A
- COR $6.47
- P/E Ratio
- ING $12.41
- COR $32.14
- Revenue Growth
- ING N/A
- COR 12.12
- 52 Week Low
- ING $12.78
- COR $214.77
- 52 Week High
- ING $18.72
- COR $253.27
- Technical
- Relative Strength Index (RSI)
- ING 60.55
- COR 64.12
- Support Level
- ING $15.53
- COR $233.61
- Resistance Level
- ING $16.49
- COR $241.14
- Average True Range (ATR)
- ING 0.17
- COR 3.94
- MACD
- ING 0.10
- COR 1.86
- Stochastic Oscillator
- ING 80.40
- COR 91.11
About ING ING Group N.V.
The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support—a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market-leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.
About COR Cencora Inc.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.